Literature DB >> 21934231

Hemophagocytic syndrome associated with Plasmodium falciparum infection.

P N Vinoth1, K Abilash Thomas, S Muthamil Selvan, D Febe Renjitha Suman, Julius Xavier Scott.   

Abstract

Hemophagocytic syndrome (HPS) has been associated with infections, hematological malignancies and autoimmune conditions. Malaria is rarely reported to cause HPS. We report a case of an 11-month-old infant with fever, hepatosplenomegaly, pancytopenia, high serum ferritin, hypertriglyceridemia, and bone marrow hemophagocytosis, consistent with hemophagocytic syndrome. Gametocytes of plasmodium falciparum were identified on bone marrow aspiration. Rapid recovery was observed after treatment with antimalarials.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21934231     DOI: 10.4103/0377-4929.85105

Source DB:  PubMed          Journal:  Indian J Pathol Microbiol        ISSN: 0377-4929            Impact factor:   0.740


  4 in total

Review 1.  Serum lipids and lipoproteins in malaria--a systematic review and meta-analysis.

Authors:  Benjamin J Visser; Rosanne W Wieten; Ingeborg M Nagel; Martin P Grobusch
Journal:  Malar J       Date:  2013-12-07       Impact factor: 2.979

2.  Malaria-associated secondary haemophagocytic lymphohistiocytosis: Report of two cases & a review of literature.

Authors:  Valliappan Muthu; Sahajal Dhooria; Inderpaul Singh Sehgal; Ritesh Agarwal; Digambar Behera; Neelam Varma
Journal:  Indian J Med Res       Date:  2017-03       Impact factor: 2.375

3.  A Case of Malaria-Associated Hemophagocytic Lymphohistiocytosis.

Authors:  Mohamed Ramzi Almajed; Renato Cerna-Viacava; Jennifer Priessnitz; Naoshin Khan; Marcus Zervos
Journal:  Cureus       Date:  2022-08-25

4.  Plasmodium falciparum and Mycoplasma pneumoniae co-infection presenting with cerebral malaria manifesting orofacial dyskinesia and haemophagocytic lymphohistiocytosis.

Authors:  Praveen Weeratunga; Gowri Rathnayake; Ahalya Sivashangar; Panduka Karunanayake; Ariaranee Gnanathasan; Thashi Chang
Journal:  Malar J       Date:  2016-09-08       Impact factor: 2.979

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.